Ocean Biomedical Inc 's ROA from the first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Ocean Biomedical Inc 's ROA in the first quarter of 2025?
Ocean Biomedical Inc recorded a cumulative net loss of $-27 million during 12 months ending in the first quarter of 2025, resulting in a negative return on assets (ROA) of -1746.28%.

However, within the Healthcare sector 1013 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2025 quarter, so far to 4970, from total ROA ranking in the fourth quarter of 2024 at 5619.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Total Assets Change	-61.35 %	-88.85 %	18.53 %	12.22 %	-83.16 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-27	-8	-25	-35	-29
Return On Assets (TTM)	-1746.28 %	-350.71 %	-596.28 %	-855.81 %	-726.29 %
OCEA's Total Ranking	# 4970	# 5619	# 5061	# 5149	# 5216
Total Assets (TTM) in million	2	1	1	2	4
Seq. Total Assets Change	59.48 %	-18.82 %	-49.61 %	-40.75 %	-53.98 %
Seq. Net Income Change	-	-	-	-	-

OCEA's 5 Years Annual ROA >> Back to OCEA Management Effectiveness >> Compare OCEA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 497
Sector	# 1014
Overall	# 4889

Return On Assets Statistics
High	Average	Low
-0.32 %	-1526.72 %	-7280.9 %
		(Sep 30 2023)

Financial Statements
Ocean Biomedical Inc 's Assets	$ 2 million	OCEA's Balance sheet
Ocean Biomedical Inc 's Income	$ -7 million	Quarterly OCEA's Income Statement
OCEA's Income by Division		See OCEA's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	FY
Y / Y Total Assets Change	-88.85 %	1800.26 %	-69.81 %	-	-
Total Assets in million	1	9	0	2	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-9	-114	-1	-1	0
Annual Return On Assets	-955.65 %	-1287.15 %	-204.8 %	-36.4 %	-

OCEA's 5 Years Annual ROA >> Back to OCEA Management Effectiveness >> Compare OCEA ROA to its Competitors

More Return On Assets Ratios
OCEA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OCEA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for OCEA's Competitors
Subscribers only: Roa for Ocean Biomedical Inc 's Suppliers
Subscribers only: Return On Assets for OCEA's Customers

You may also want to know
OCEA's Roi	OCEA's Inventory Turnover Ratio	OCEA's Growth Rates	OCEA's Dividend Comparisons
	OCEA's Profitability Ratios	OCEA's Asset Turnover Ratio	OCEA's Dividend Growth
OCEA's Roe	OCEA's Valuation Ratios	OCEA's Financial Strength Ratios	OCEA's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:40:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.